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In this report, we describe a Korean patient with May-Hegglin anomaly from a mu-
tation of the MYH9 gene. The proband was a 21-year-old man with thrombocytope-
nia. He did not have a bleeding tendency. His neutrophil count was normal at 7490/
mm3; however, the neutrophils contained abnormal basophilic inclusions in their 
cytoplasm. The platelet count was decreased at 15000/mm3 with giant platelets. Co-
agulation test results were not remarkable. Direct sequencing of MYH9 revealed 
that he was heterozygous for a mutation in exon 1, which was a 97T>A substitution 
mutation affecting codon 33, substituting tryptophan with arginine (Trp33Arg). 
Family study showed that both of his parents had normal phenotype and genotypes, 
indicating a de novo occurrence of the mutation in the proband.
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INTRODUCTION
May-Hegglin anomaly (MHA) is a rare autosomal dominant disorder character-
ized by giant platelets and pale-blue inclusions in leukocytes. The clinical charac-
teristics and the hereditary pattern of MHA were first described in 1909 and 1945, 
respectively.1,2 The mutated gene is the gene encoding myosin heavy chain 9 
(MYH9) located on chromosome band 22q12-13, which is comprised of 40 exons 
encoding the nonmuscle myosin heavy-chain IIA (NMMHC-IIA), a cytoskeletal 
contractile protein.3,4 In this report, we describe a Korean patient with MHA from 
a missense mutation in exon 1 of MYH9.
CASE REPORT
The proband, a 21-year-old Korean soldier, was referred to Bundang CHA Medical 
Center because of thrombocytopenia. He had been diagnosed as having giant plate-
let syndrome 8 years previously in a tertiary hospital without further investigation A Mutation Trp33Arg of the MYH9 Gene
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the authors (available upon request). Direct sequencing was 
performed using the same primers. The mutation identified 
was described according to the guidelines by the Human 
Gene Variation Society (http://www.hgvs.org/mutnomen/), 
having the A of the ATG-translation initiation codon as +1 
at the nucleotide level and the 1st Met as +1 at the protein 
level. The direct sequencing of the MYH9 gene in the pa-
tient showed that he was heterozygous for a missense mu-
tation in exon 1 of MYH9. The mutation was a transversion 
variation (c.97T>A) substituting the 33rd residue trypto-
phan with arginine (p.Trp33Arg) (Fig. 1B).
Wright-Giemsa stain of peripheral blood showed cyto-
plasmic inclusion in neutrophils (Fig. 2A). Immunofluores-
cence analysis of neutrophil NMMHC-IIA showed abnor-
mal diffuse NMMHC-IIA localization, with several circular 
to oval cytoplasmic inclusions (Fig. 2B). The family study 
showed that both of his parents and his brother had normal 
phenotype and genotypes, indicating a de novo occurrence 
of the mutation in the proband.
or follow-up. Recently he was found to have thrombocyto-
penia on routine health checkup at an army hospital. He 
had no personal or familial history of a bleeding tendency. 
Complete cell counts at the present visit showed a platelet 
count at 36000/mm3. Peripheral blood smear revealed giant 
platelets and basophilic oval-shaped inclusion bodies in the 
cytoplasm of granulocytes. Based on the history and labora-
tory findings, he was suspected to have MHA, one of the 
MYH9-related disorders. His parents and younger brother 
paid a visit for family study and had their blood drawn for 
cell counts and molecular genetic analyses (Fig. 1A).
To confirm the diagnosis of May-Hegglin anomaly dis-
ease, molecular genetic analysis was performed with in-
formed consent provided by the patient and family mem-
bers. DNA was extracted from leukocytes obtained from 
peripheral blood using the Wizard genomic DNA purifica-
tion kit (Promega, Madison, WI, USA). All exons and their 
flanking intronic sequences of MYH9 were amplified by 
polymerase chain reaction by pairs of primers designed by 
Fig. 1. (A) The pedigree of the patient (arrow). (B) The results of direct sequencing of MYH9 in the proband and family members. The proband was heterozy-
gous for a missense mutation, c.97T>A, p.Trp33Arg. His parents did not have the mutation, indicating a de novo occurrence of the mutation in the proband. 
His brother was also homozygous for the wild-type sequence, as were his parents.
Fig. 2. (A) Cytoplasmic inclusion in neutrophils (Wright-Giemsa ×1000). (B) Diffuse granular pattern of fluorescence signals from anti-NMMHC-A antibody in 
neutrophils.
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Table 1. Mutations and Clinical Features in MYH9-Related Thrombocytopenia
5-7,16,19-24
Exon Mutation Number of 
affected families Thrombocytopenia Hearing loss Renal impairment Cataract
  1 W33R 3 + - - -
  1 W33C 2 + + - -
  1 P35A 1 + - - -
  1 L46F 2 + + NA NA
  1  N93D 1 + + NA NA
  1 N93K 2 + - - -
  1 A95T 1 + - - -
  1 A95V 3 + - - -
  1 S96L 4 + + + -
10 K371N 1 + - - -
16 R702C 7 + + + +
16 R702H 4 + + + +
16 R705H 1 - + NA NA
16 Q706E 1 + NA NA NA
16 R718W 2 + + + +
20 K850E 2 + + - -
21 E894K 2 + + - -
24 E1066-A1072del 1 + - - +
25 V1092-R1162del 1 + - + -
25 D1114P 1 + - + -
26 T1155A 1 + + + +
26 T1155I 5 + - - -
26 R1165C 5 + + + +
26 R1165L 2 + + + +
26 L1205-Q1207del 1 + - - -
30 R1400W 2 + - + -
30 D1424Y 2 + + + +
30 D1424N 13 + + + +
30 D1424H 3 + + + +
30 D1424G 1 + + - -
30 A1436T 1 + - - -
30 D1447V 1 + NA NA NA
31 E1475K 1 + - - -
31 V1516L 1 + NA + +
31 V1560G 1 + - - -
32 Q1563K 2 + - - -
37 I1816V 1 + + + -
38 E1841K 21 + - + +
40 G1924fs 1 + NA NA NA
40 D1925fs 1 + - - -
40 P1927fs 1 + - - -
40 R1933fs 1 + - - -
40 R1933X 14 + + + -
40 G1940R 1 + NA NA NA
40 E1945 2 + - + -
NA, no data available; fs, frameshift; del, deletion.A Mutation Trp33Arg of the MYH9 Gene
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port showed no evidence of hearing or renal impairment. 
However, further monitoring is needed for the possible de-
velopment of these complications. 
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